While alterations in the regulation of circadian clock machinery, which acts as a tumor suppressor, have been reported in tumor cells of AA patients [41], our findings highlight the involvement of the tumor microenvironment, TAS, in these processes. The gene discussed is CLOCK; the disease is neoplasm.